Medicine and Dentistry
Bacteremia
73%
Staphylococcal Bacteremia
62%
Staphylococcus Aureus
54%
Cohort Analysis
41%
Infection
27%
Infective Endocarditis
26%
Escherichia coli
25%
Symptom
20%
Prevalence
18%
Patient with Diabetes
16%
Endocarditis
16%
Patient Registry
15%
Diabetes
14%
Diagnosis
12%
Vogt Koyanagi Syndrome
12%
Echocardiography
12%
Seasonal Variation
12%
Penicillinase
12%
Candidemia
12%
Patient Characteristics
12%
Bloodstream Infection
12%
Virus Meningitis
12%
Differential Diagnosis
12%
Heart Failure
12%
Streptococcus Pneumoniae
12%
Permanent Pacemaker
12%
Sex Difference
12%
Defibrillator
12%
Extended Spectrum Beta Lactamase
12%
Whole Genome Sequencing
12%
Case-Control Study
12%
Odds Ratio
9%
Blood Culture
8%
Urinary Tract Infection
6%
Mortality Rate
5%
Hazard Ratio
5%
Antibiotic Therapy
5%
Keyphrases
Staphylococcus Aureus Bacteremia
75%
CA-MRSA
50%
Historical Population
25%
Statin Use
16%
Decreased Risk
16%
Confidence Interval
16%
Infective Endocarditis
15%
Community Hospital
12%
Patient Outcomes
12%
Health Care Acquired
12%
Echocardiography
12%
Community Health Care
12%
Patient Characteristics
12%
S. Aureus Bacteremia
12%
Impulse Generator
12%
Viral Meningitis
12%
Vogt-Koyanagi-Harada Syndrome
12%
Healthcare-associated
12%
Network Database
12%
Klebsiella Pneumoniae Bacteremia
12%
Population-based Study
12%
Population-based Case-control Study
12%
Klebsiella Pneumoniae Infection
12%
Producing Escherichia Coli
12%
Acetylsalicylic Acid
12%
Population-based Cohort Study
12%
Gender Differences
12%
Diagnostic Confirmation
12%
Long-term Users
11%
Statins
11%
Hospital Acquisition
10%
Community Acquisition
10%
Current Users
10%
Co-resistance
10%
Adjusted Odds Ratio
9%
Population Control
8%
Female Patients
8%
30-day Mortality
7%
Escherichia Coli Bacteremia
7%
New User
7%
Prevalence Characteristics
6%
Healthcare-associated Infections
6%
Staphylococcus Aureus
6%
Medical Conditions
6%
High Morbidity
6%
Epidemiol
6%
Causative Microorganisms
6%
Local Sign
6%
Device Extraction
6%
Coagulase-negative Staphylococci (CoNS)
6%
Pharmacology, Toxicology and Pharmaceutical Science
Staphylococcal Bacteremia
100%
Case-Control Study
38%
Bacteremia
33%
Cohort Study
26%
Statin (Protein)
20%
Infection
20%
Staphylococcus Aureus
15%
Comorbidity
13%
Staphylococcal Pneumonia
12%
Prevalence
12%
Anticoagulation Therapy
12%
Candidemia
12%
Thromboembolism
12%
Streptococcus Pneumoniae
12%
Acetylsalicylic Acid
12%
Escherichia Coli Pneumonia
12%
Heart Failure
12%
Penicillinase
12%
Klebsiella Pneumoniae Infection
12%
Atrial Fibrillation
12%
Glucocorticoid
12%
New-Onset Atrial Fibrillation
12%
Escherichia coli
12%
Mortality Rate
6%
Healthcare Associated Infection
6%
